Arteritis Clinical Trials

53 recruitingLast updated: May 13, 2026

There are 53 actively recruiting arteritis clinical trials across 15 countries. Studies span Phase 4, Phase 2, Not Applicable, Phase 3. Top locations include Hamilton, Ontario, Canada, Toronto, Ontario, Canada, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Arteritis Trials at a Glance

53 actively recruiting trials for arteritis are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Phase 4 with 6 trials, with the heaviest enrollment activity in Hamilton, Toronto, and Philadelphia. Lead sponsors running arteritis studies include University of Pennsylvania, University of Bonn, and Shanghai Zhongshan Hospital.

Browse arteritis trials by phase

Treatments under study

About Arteritis Clinical Trials

Looking for clinical trials for Arteritis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Arteritis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Arteritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Giant Cell Arteritis (GCA)Ischemic Optic NeuropathyNAION - Non-Arteritic Ischemic Optic Neuropathy
Rigshospitalet, Denmark122 enrolled1 locationNCT07206238
Recruiting
Phase 2

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Giant Cell Arteritis
Insel Gruppe AG, University Hospital Bern70 enrolled1 locationNCT06335888
Recruiting

Global Initiative on Takayasu Arteritis (GITA)

Takayasu's ArteritisTakayasu Arteritis (TAK)
Marmara University1,000 enrolled2 locationsNCT07558382
Recruiting
Phase 4

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital477 enrolled2 locationsNCT07087912
Recruiting

The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.

Giant Cell Arteritis (GCA)
Vastra Gotaland Region340 enrolled1 locationNCT07246577
Recruiting
Phase 2

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Giant Cell Arteritis (GCA)
National Institute of Allergy and Infectious Diseases (NIAID)78 enrolled7 locationsNCT07108387
Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

ANCA-associated VasculitisGiant Cell ArteritisTakayasu's Arteritis+2 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4,000 enrolled1 locationNCT02257866
Recruiting
Not Applicable

Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

Takayasu Arteritis
Marmara University40 enrolled1 locationNCT07491913
Recruiting

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Giant Cell Arteritis
University Hospital, Brest100 enrolled2 locationsNCT06894602
Recruiting
Phase 4

Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency

Adrenal InsufficiencyGiant Cell ArteritisPolymyalgia Rheumatica
Marianne Christina Klose250 enrolled3 locationsNCT05435781
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

IgA VasculitisHenoch-Schönlein PurpuraPrimary Cutaneous Vasculitis+1 more
University of Pennsylvania90 enrolled16 locationsNCT02939573
Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

VasculitisIgA VasculitisMicroscopic Polyangiitis (MPA)+7 more
Peter Merkel50 enrolled10 locationsNCT03004326
Recruiting

Vasculitis Pregnancy Registry

Behcet's DiseaseVasculitisCNS Vasculitis+12 more
University of Pennsylvania100 enrolled1 locationNCT02593565
Recruiting

VCRC Tissue Repository

Microscopic PolyangiitisGiant Cell ArteritisTakayasu Arteritis+8 more
University of Pennsylvania1,000 enrolled8 locationsNCT02967068
Recruiting

One-Time DNA Study for Vasculitis

Microscopic PolyangiitisGiant Cell ArteritisTakayasu's Arteritis+3 more
University of Pennsylvania1,000 enrolled14 locationsNCT01241305
Recruiting
Phase 3

Abatacept for the Treatment of Giant Cell Arteritis

Giant Cell Arteritis
University of Pennsylvania78 enrolled9 locationsNCT04474847
Recruiting
Phase 2

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Giant Cell Arteritis (GCA)Takayasu ArteritisLarge Vessel Vasculitis
University of Edinburgh60 enrolled1 locationNCT06887062
Recruiting

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

Takayasu ArteritisTakayasu Arteritis (TAK)
University of Edinburgh50 enrolled1 locationNCT07351422
Recruiting

Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)

Giant Cell Arteritis
Fondation Ophtalmologique Adolphe de Rothschild133 enrolled1 locationNCT05854927